tranexamic acid has been researched along with Autoimmune Disease in 4 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rampotas, A | 1 |
| Watson, E | 1 |
| Burton, K | 1 |
| Hill, QA | 1 |
| Pavord, S | 1 |
| Cugno, M | 1 |
| Cicardi, M | 2 |
| Agostoni, A | 2 |
| Castelli, R | 1 |
| Gardinali, M | 1 |
| Zingale, LC | 1 |
| Savi, C | 1 |
| Munari, M | 1 |
| Nymand, G | 1 |
| Dyerberg, J | 1 |
4 other studies available for tranexamic acid and Autoimmune Disease
| Article | Year |
|---|---|
A real-world study of immune thrombocytopenia management during the COVID-19 pandemic in the UK.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Autoimmune Diseases; Combined M | 2022 |
Activation of the contact system and fibrinolysis in autoimmune acquired angioedema: a rationale for prophylactic use of tranexamic acid.
Topics: Acute Disease; Aged; Angioedema; Autoantibodies; Autoimmune Diseases; Complement C1 Inactivator Prot | 1994 |
Cardiopulmonary by-pass in a patient with acquired C1 inhibitor deficiency.
Topics: Aged; Anabolic Agents; Angioedema; Antifibrinolytic Agents; Aprotinin; Autoimmune Diseases; Calcium | 1997 |
Letter: Tranexamic acid: a new approach to autoimmune disease?
Topics: Aged; Autoimmune Diseases; Cyclohexanecarboxylic Acids; Humans; Lupus Erythematosus, Systemic; Male; | 1975 |